SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950123-11-054482
Filing Date
2011-05-26
Accepted
2011-05-26 16:44:50
Documents
1
Group Members
BRADBURY DYER IIIPARAGON ASSOCIATES AND PARAGON ASSOCIATES II JOINT VENTURE

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A c18055sc13dza.htm SC 13D/A 47240
  Complete submission text file 0000950123-11-054482.txt   48937
Mailing Address 25 UPTON DRIVE WILMINGTON MA 01887
Business Address 25 UPTON DRIVE WILMINGTON MA 01887 9786577500
DUSA PHARMACEUTICALS INC (Subject) CIK: 0000879993 (see all company filings)

IRS No.: 223103129 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-42248 | Film No.: 11874619
SIC: 2834 Pharmaceutical Preparations

Mailing Address 500 CRESCENT COURT SUITE 260 DALLAS TX 75201
Business Address 500 CRESCENT COURT SUITE 260 DALLAS TX 75201 2148713700
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE (Filed by) CIK: 0001047859 (see all company filings)

IRS No.: 751956332 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13D/A